West Pharm Svcs Stock Price, News & Analysis

West Pharmaceutical Services, Inc. (NYSE: WST) has announced a quarterly dividend of $0.19 per share, payable on May 3, 2023, to shareholders recorded as of April 26, 2023. This dividend reflects the company's ongoing commitment to returning value to its shareholders. In fiscal year 2022, West generated $2.89 billion in net sales, marking a significant milestone in its 100-year history of innovation in the injectable solutions market. The company supports pharmaceutical developers with reliable containment and delivery solutions, underscoring its critical role in healthcare.

West Pharmaceutical Services, Inc. (NYSE: WST) reported its fourth-quarter and full-year 2022 results, indicating a 3.0% decline in Q4 net sales to $708.7 million, with organic growth of 2.6%. Full-year 2022 net sales reached $2.887 billion, growing by 2.0% with 7.7% organic growth. Reported diluted EPS for Q4 was $1.36, dropping 29.5%, while full-year diluted EPS decreased 10.8% to $7.73. For 2023, the company expects net sales between $2.935 billion and $2.960 billion, with adjusted diluted EPS guidance of $7.25 to $7.40. A $1 billion share repurchase program was approved, with a focus on HVP manufacturing capacity to meet growing demand.

West Pharmaceutical Services (NYSE: WST) announced the expansion of its collaboration with Corning Incorporated, granting exclusive distribution rights for Corning Valor® Glass vials. The first product, West Ready Pack™ with Corning Valor® RTU Vials, uses SG EZ-fill® technology and aims to improve the packaging and delivery of injectable drugs. This collaboration, which includes a multimillion-dollar investment started in January 2022, focuses on enhancing patient safety and expanding access to healthcare. The combined system boasts benefits like proven container closure integrity and a sterile, ready-to-use design.

West Pharmaceutical Services (NYSE: WST) will release its fourth-quarter and full-year 2022 financial results on February 16, 2023, before market opening. A conference call to discuss these results will follow at 9:00 a.m. Eastern Time. Investors can access the live audio-only webcast via the Company’s Investor Relations website and participate by registering in advance. West will also attend the Barclays Global Healthcare Conference in Miami on March 14, 2023, and the KeyBanc Life Sciences & MedTech Investor Forum virtually on March 22, 2023. West, celebrating 100 years of innovation, generated $2.83 billion in net sales in FY 2021.

West Pharmaceutical Services (NYSE: WST) announced its participation at Pharmapack Europe 2023, showcasing innovations in injectable drug packaging. The company introduced three new products: West Ready Pack™ with Corning Valor® RTU Vials, Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System, and FluroTec® 5-10mL Cartridge Plunger. These innovations aim to address the demands of complex drug delivery and enhance patient safety. Additionally, West's presentations include discussions on market trends and innovations in drug delivery systems, highlighting the company's ongoing commitment to improving patient adherence and pharmaceutical solutions.

West Pharmaceutical Services, Inc. (NYSE: WST), a leader in injectable drug solutions, will present at the 41^st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 12, 2023, at 9:00 am PST. A live audio webcast will be available on the company's website, with a replay accessible for 90 days. With nearly 10,000 employees across 50 sites, West generated $2.83 billion in net sales in 2021, providing crucial containment and delivery services for medicines worldwide. For more insights, visit www.westpharma.com.

West Pharmaceutical Services, Inc. (NYSE: WST) has declared a first-quarter 2023 dividend of $0.19 per share, payable on February 1, 2023, to shareholders of record by January 25, 2023. The company reported $2.83 billion in net sales for its fiscal year 2021, highlighting its position as a leader in injectable drug administration solutions. West will also participate in the CJS Securities 23rd Annual "New Ideas for the New Year" Conference on January 11, 2023, at 3:05 pm ET.

West Pharmaceutical Services, Inc. (NYSE: WST) announced participation in two key investor conferences. The company will present at the Jefferies London Healthcare Conference on November 15, 2022, at 3:50 PM GMT, and at the Stephens Annual Investment Conference in Nashville, TN, on November 17, 2022, at 2:00 PM CT. Live audio webcasts of both presentations will be available on the company's website, with replays accessible for 90 days post-event. West generated $2.83 billion in net sales in fiscal year 2021 and operates about 50 sites globally, employing approximately 10,000 team members.

West Pharmaceutical Services, Inc. (NYSE: WST) will participate in CPhI Worldwide in Frankfurt, Germany, on November 1, 2022. The company aims to address industry challenges in packaging and containment. Chris Ryan, VP at West, emphasized their collaboration with Corning for advanced solutions in lyophilization and closure integrity. Experts will present on elastomer formulations and container closure systems at scheduled speaking sessions. West, headquartered in Exton, Pennsylvania, reported $2.83 billion in net sales in fiscal year 2021.